It is also associated with PCa progression, mainly through the activation of the PI3K/Akt/mTORC1 pathway, with a recent study suggesting the potential therapeutic benefit of its inhibition to overcome resistance to anti-androgen treatment (52). Here, AKT1 is linked to posterior cortical atrophy.